These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1889766)

  • 1. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP; Kampik A
    Fortschr Ophthalmol; 1991; 88(3):219-24. PubMed ID: 1889766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
    Heidenkummer HP; Kampik A
    Ger J Ophthalmol; 1992; 1(3-4):170-5. PubMed ID: 1483131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases.
    Heidenkummer HP; Kampik A; Petrovski B
    Retina; 1992; 12(1):52-8. PubMed ID: 1565872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent vitreoretinal membranes in intravitreal silicon oil tamponade. Morphologic and immunohistochemical studies].
    Heidenkummer HP; Messmer EM; Kampik A
    Ophthalmologe; 1996 Apr; 93(2):121-5. PubMed ID: 8652975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical findings of epiretinal membranes after silicone oil injection].
    Nicolai U; Eckardt C
    Fortschr Ophthalmol; 1991; 88(6):660-4. PubMed ID: 1724441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
    Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
    Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
    Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
    Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Augustin AJ; Spitznas M; Koch F; Grus F; Böker T
    Ger J Ophthalmol; 1995 Jan; 4(1):47-51. PubMed ID: 7728110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG; Brem RB; Wilson DJ; O'Rourke LM; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
    Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
    Snead DR; James S; Snead MP
    Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1991; 88(4):337-40. PubMed ID: 1786916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
    Briggs MC; Grierson I; Hiscott P; Hunt JA
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
    Kirchhof B; Sorgente N
    Dev Ophthalmol; 1989; 16():1-53. PubMed ID: 2676632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
    Lashkari K; Rahimi N; Kazlauskas A
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical findings in proliferative retinal diseases--on the significance of fibronectin, macrophages and transferrin].
    Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1989; 86(2):121-3. PubMed ID: 2661370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of epidermal growth factor receptor in a human epiretinal membrane.
    Heidenkummer HP; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):492-6. PubMed ID: 1718825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.